‘Pfizer Inc. has filed a patent infringement suit against generic drug makers Teva Pharmaceutical Industries Ltd. and Sandoz Inc. concerning generic versions of the antibiotic Zithromax.

Representatives from Sandoz, based in Princeton, N.J., and Teva, based in Israel, couldn’t immediately be reached for comment.

In a press release Wednesday, Pfizer also said it filed a petition with the U.S. Food and Drug Administration, claiming Teva’s and Sandoz’s azithromycin product labels do not accurately describe the drug’s active ingredients. ‘

Read more at Pfizer Sues Teva, Sandoz Over Zithromax

Recent Entries

• Sigma Pharmaceuticals year profit rises 27 pct
• South African citizens cheap drug guinea pigs
• Two drugs test victims face a year in coma
• Can drug companies improve their reputation?
• Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
• Pfizer’s Forecast Disappoints
• Pharmaceutical RFID Adoption Stalls
• Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
• GlaxoSmithKline unveils best results since merger
• Pfizer Sues Teva, Sandoz Over Zithromax

This entry was posted on Thursday, February 9th, 2006 at 10:21 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.